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Organotypic Culture of Fetal Lung Type 11
Alveolar Epithelial Cells: Applications to
Pulmonary Toxicology
by Susan G. Shami,*t Jane D. Aghajanian**
and Ronald L. Sanders*
Techniques for isolation and culture offetal lype II alveolar epithelial cells, as well as the morphologic
and biochemical characteristics of these histotypic cultures, are described.
Type II alveolar epithelial cells can be isolated from fetal rat lungs and grown in an organotypic culture
system as described in this review. The fetal Type II cells resemble differentiated rat Type II cells in
morphology, biochemistry, and karyotype as they grow in culture for up to 5 weeks. The cells ofthe mature
organotypic cultures form alveolarlike structures while growing on a gelatin sponge matrix. The Type II
cells also synthesize and secrete pulmonary surfactant similar in biochemical composition to that
produced in vivo. This system has been used to study the effects ofhormones on surfactant production and
composition. Theorganotypic model has manypotential applications tothe study ofpulmonary toxicology.
Introduction
The alveolar region of the lung is lined by a continu-
ous epithelium consisting of two morphologically and
functionally distinct celltypes. These arethe Type I cell,
a squamous cell which acts as a protective barrier while
allowing gas exchange, and the Type II cell, a cuboidal
cell with characteristic inclusion bodies or lamellar
bodies in the cytoplasm. Pulmonary surfactant is syn-
thesized by the Type II cell and stored inthese inclusion
bodies (1). Surfactant is alipoprotein complex lining the
alveolar epithelium (2-4) and reducing surface tension
(5); the low surface tension prevents alveolar collapse
(6,7). Surfactant may also aid in preventing pulmonary
edema (8,9) and may enhance the bactericidal action of
macrophages and aid in the clearance of particulates
(10,11). In addition to producing surfactant, the Type II
cell also serves as the stem cell for the Type I cell
(12,13), forming the basis forthe renewal ofthe alveolar
epithelium.
Pulmonarydisordersfrequentlyoriginateinthealveo-
lar region ofthe lung. In human infants, a deficiency in
surfactant is thought to be a cause of the respiratory
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distress syndrome (5). Both lype I andType II cells are
the targets of many toxic and carcinogenic agents in
experimental animals as well as in humans (14). These
toxic agents include gases such as NO2 (15), ozone
(15,16) and oxygen (17); metals such as cadmium (18)
and metal salts (19); and drugs and chemicals such as
BHT (20), bleomycin (21), lysolecithin (22), the hypo-
cholesteremic drug AY9944 (23), Freund's adjuvant
(24), and trypsin (25).
Thelungcontainsnumerouscelltypes(26). Therefore,
in order to study the effects oftoxic substances on the
Type II cell and on surfactant production, it is advanta-
geous to work with a population enriched in Type II
cells maintained in tissue culture. Subtle effects on
metabolism ofthe Type II cell will be more apparent in
such a system. In addition, it is possible to control the
environment of the Type II cell more closely when a
tissue culture system is utilized. An organotypic model
offetal alveolar lung cells has been developed (27-29) in
which the morphology and biochemical functions ofthe
rEype II pneumonocyte can be maintained in vitro for a
period of several weeks. This model has been used to
studythe biochemistry ofsurfactant production (30-32)
and could well be applied to the study of pulmonary
toxicology. Although there are several cell culture
systems for the study of Type II pneumonocytes
(33-43), the organotypic model has certain advantages.
It consists of an enriched population of Type II cells
which grow in an alveolar rather than a monolayer
pattern permitting cell to cell contacts and interactionsSHAMI, AGHAJANIAN AND SANDERS
similar to the in vivo situation. In addition, the fetal TEype II cells present initially in culture continue to
differentiate and mature into a population of metaboli-
callyactiveType II alveolarpneumonocytesthatsynthe-
size and secrete pulmonary surfactant.
The dissociation offetal tissue into single cells and its
subsequent reaggregation into histotypic structures was
first described by Moscona (44,45). Histotypic reaggre-
gation has been described forfetal heart (46), brain (47),
kidney (48) and liver (49). When dissociated, fetal rat
lung cells reaggregate to form histotypic structures in a
gelatin sponge matrix (Gelfoam) (28,29). Initially, these
histotypic structures resemble the epithelial tubules of
the fetal lung, containing pyramidally shaped columnar
cells with glycogen accumulations in the cytoplasm (50).
As they mature in culture, the cells in the histotypic
structures begin to resemble differentiated Type II
pneumonocytes which form alveolarlike structures
(ALS) (28,29). Surfactant is synthesized, packaged into
lamellar bodies and released into the lumina ofthe ALS
by the Type II pneumonocytes present in the organo-
typic culture system (32). This surfactant can be col-
lected by sucrose density centrifugation (51). Analysis
ofthe phospholipids ofthe surfactant isolated from the
organotypic cultures indicates that they are similar to
the phospholipids present in whole lung (32).
In this paper we describe the techniques for isolation
and culture of the fetal Type II alveolar epithelial cells
as well as the morphologic and biochemical characteris-
tics of these histotypic cultures. In addition, the re-
sponse ofthis system to certain hormones is described.
Methods
It has been demonstrated that cellular reaggregation
is dependent upon the presence ofcell surface receptors
(52-55). Reaggregation of fetal alveolar epithelial cells
into histotypic structures is dependent upon methods
used for isolation and culture ofthe cells. The isolation
and culture methods have been reported in detail
previously (28,29,56) and arereviewed here. Fetuses are
aseptically obtained from pregnant rats at days 16
through 19 of gestation, and the lungs are removed,
washed and minced. The lung tissue is then dissociated
by a series of enzymatic digestions. The enzyme mix-
ture consists oftrypsin, collagenase, and chick serum in
Moscona's saline. The freshly isolated cells are centri-
fuged and the cell pellet is incubated at 37°C for 1 hr.
This 1-hr incubation is necessary for the resynthesis of
cell-ligand components on the cell membrane (28). The
cells are then resuspended in medium (RPMI-1640
supplemented with 10% selected fetal bovine serum)
and aliquots of 107 viable cells are inoculated onto
Gelfoam sponges (Gelfoam, The Upjohn Co., Kala-
mazoo, MI) which have been hydrated with medium.
The sponges are incubated for 1 hr in Petri dishes at
37°C in a humidifed atmosphere of 5% CO2 in air in
order to allow the cells to attach to the Gelfoam matrix.
Culture medium is then added to the dishes and they
are incubated under the same conditions. After 2 days,
the cultures are placed on a rocker platform set at 3
cycles/min. The culture medium is replaced every 2
days.
The ALS can be identified and assessed by staining
with tetrazolium chloride (TTC). The cultures are
incubated at 37°C with 0.05 to 1.0% of 2,3,5'-triphenyl
tetrazolium chloride for 40 to 50 min. They become
bright red in color as oxidative enzyme systems reduce
the colorless tetrazole to the insoluble red-colored
formazan. This staining technique has two specific
applications to the organotypic model. It allows localiza-
tion ofthe cells inthe Gelfoammatrix suchthatthey can
be easily processed for morphological studies. In
addition, TTC stainingindicates the viability ofthe cells
(57). Quantitative viability assays may be done using
acetone-extracted formazan (58). Cells killed by glutar-
aldehyde fixation, freeze-thawing, or heating do not
stain with TTC (57). TTC staining is routinely used to
screen cultures before processing them for biochemical
studies of surfactant (57). The technique might also be
used to screen the effects of various toxic agents upon
the Type II cells in the organotypic cultures.
Characteristics ofthe Culture System
The enzymatically dissociated fetal lung cells are
initially in a monodisperse condition. They begin to
reaggregate in vitro within 24 hr and within 2 days they
form alveolarlike structures (ALS) within the Gelfoam
matrix (28). These ALS can be maintained for 5 weeks
in culture (28). Cells from younger fetuses (16 to 17 days
of gestation>birmin ALS earlier than cells from 19- to
20-day fetuses Cg1). Initially, ALS are lined by a single
layer ofundifferentiated epithelial cells and are 12 to 50
,um in diameter (28). With time, these cells comprising
the ALS differentiate into mature TIype II alveolar
epithelial cells while the ALS increase in diameter (31).
The increase in size is most likely due to the addition of
cells which were previously free, or coalescing of
separate ALS, or a combination ofthe two since mitotic
activity inthese lungcells is minimal (31). Figures 1 and
2 demonstrate the appearance of ALS within the
Gelfoam matrix after 7 and 22 days in culture.
Initially, the alveolarlike structures are surrounded
by a loose meshwork offibroblastlike cells. With time in
culture these fibroblastlike cells condense into a dense
mesenchymal matrix which may be one to several layers
ofcells in thickness (31). This mesenchymal matrix may
be quite important to the functional and morphological
development ofthe Type II cells ofthe ALS. Smith (59)
has described a fibroblast-pneumonocyte factor which
fetal lung fibroblasts produce upon glucocorticoid
stimulation. This factorinduces the fetal lungto mature
in vitro without a corresponding decrease in growth
rate. In addition, Master (60) has demonstrated that, in
the mouse lung in organ culture, the amount ofmesen-
chyme in the system regulates growth and differentia-
tion of the epithelial cells.
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FIGURE 1. Photomicrograph ofanalveolarlike structureafter22days
in vitro. Type II cells in the ALS have a euchromatic nucleus (n)
with osmiophilic inclusion bodies in their cytoplasm (0). The Type
II cells surround the lumen (L) of the ALS. Fibroblasts (F) are
present at the periphery of the ALS between the ALS and the
Gelfoam matrix (G). Magnification: x1,000.
The undifferentiated cells that originally comprise
the ALS contain abundant glycogen. This glycogen is
lost as these cells differentiate into TIype II alveolar
epithelial cells. Like Type II cells in vivo, the Type II
cells in organotypic culture are cuboidal with apical
microvilli and a euchromatic nucleus (1). They contain
osmiophilic lamellar bodies resembling those formed in
vivo (35,61). The lamellar bodies are released into the
lumina of the ALS where they form tubular myelin
figures (31). Desmosomes and tight junctions join the
apical surfaces of cells in the ALS; other regions of
contact between the cells are interdigitating folds (28).
This morphology ofthe Type II cell is maintained for 5
weeks in culture (31). Most of the cells in the culture
exhibit a diploid rat karyotype of42 chromosomes (31).
In addition to Type II cells, a small number of other
pulmonary cell types may be found in these cultures.
Occasional ciliated cells may line the ALS after 1 week
in culture. Nonciliated cells and cells resembling endo-
crine cells may also be observed infrequently (31). After
15 days in culture, squamous epithelial cells that
resemble the Type I cell are found in the ALS (28). It is
logical to assume that these squamous cells are, in fact,
Tpype I pneumonocytes because the Type II cell is the
stem cell for the Type I cell in vivo (13).
The organotypic cultures, after 1 week in culture, are
used routinely to study the synthesis ofsurfactant (32).
Surfactant is isolated by the method of Frosolono (51)
and has been found to be similar in composition to that
isolated from adult rat lung (32). Table 1 gives propor-
tions ofthe major surfactant components in whole lung
and in organotypic cultures. It should be noted that
there may be some differences in phospholipid composi-
tion of fetal organotypic T)ype II cells and adult whole
lung Type II cells because phospholipid composition of
surfactant does appear to change during lung develop-
ment (62) as does esterase activity (63). Any cellular
material which is not isolated with the surfactant
fraction is essentially equivalent to the lamellar body
fraction while the residual fraction approximates the
microsomal fraction (32).
The most abundant phospholipid found in the surfac-
tant fraction of the organotypic culture is phospha-
tidylcholine (PC) (72%); this percentage is similar to
that found in adult rat lung (69%). The residual frac-
tions of lung contain less PC than the surfactant
fractions (51% in the organotypic culture and 46% in
vtivo) (32). ThePC ofthesurfactantfractionoftheorgano-
typic culture is highly saturated, containing palmi-
tate (79%), myristate (9%), and stearate (8%) as the
primary fatty acids (57). These fatty acids are found in
similar concentrations in PC from adult whole rate lung
(64). The surfactant fraction contains relatively little
phosphatidylethanolamine (PE) and spingomyelin in
vitro (9% and 7%, respectively) as in vivo (10% and 5%,
respectively). Theresidualfractions inboth organotypic
cultures and in vivo contain a greater proportion ofPE
and sphingomyelin than do the surfactant fractions (31).
Exogenousglucosehasbeenmeasured asitismetabo-
lized by the organotypic cultures. The glucose may be
utilized by the Type II cell for the synthesis of both
surfactant and residual PC. Residual PC incorporates
three times more 14C-glucose than does surfactant PC.
The uptake of 14C-glucose into PC is concentration-
dependent (32) and may be stimulated by insulin expo-
sure in vitro (65).
In order to demonstrate that these organotypic
cultures actually synthesize surfactant, they have
beenincubatedwithradioactiveprecursorsofsurfactant
such as 3H-palmitate, 14C-choline, or3H-leucine. Palmi-
tate is incorporated in a linear manner into both
surfactant and residual fractions for 3 hr after which
five times more is incorporated into residual than
surfactantfractions. Cholineisincorporatedinto surfac-
tant PC in a linear fashion and into residual PC in a
biphasic manner. Incorporation of leucine into the
protein of surfactant fraction is linear for 8 hr (32).
Certain nonspecific esterases are characteristic of
mouse and rat lung homogenates (66) as well as mouse
pulmonary lavage fluid (66), lamellar body fractions
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FIGURE 2. Electron micrograph of a portion of an alveolarlike structure after 7 days in vitro. Portions of four 'Iype II cells are present.
Osmiophilic lamellar bodies (OLB) are present in thecytoplasm ofthe cells and also in the lumen (arrowhead) ofthe ALS. Microvilli (M) are
present on the apical surface of the Type II cells. Magnification: x23,200.
I, -. .4:-- .:. yI
.,- ". .;;";-
I.
..... ..,
%41,1-`,-.
of& I
P.
V - v NPAIII,A'l--,
."t,:f 11 .; 'A 1".ORGANOTYPIC CULTURE OF FETAL TYPE II CELLS
Table 1. Phospholipid composition of adult rat lung and organotypic cultures from fetal rat lung.
Rat lung' Organotypic culturesb
Surfactant, Residual, Surfactant, Residual,
Phosphatidylglycerol 6.7 ± 0.3 2.8 ± 0.2 4.0 ± 0.5 2.2 ± 0.2
Phosphatidylethanolamine 9.8 ± 0.4 23.6 ± 0.7 8.8 ± 1.8 14.2 ± 0.8
Phosphatidylserine and
phosphatidylinositol 6.1 ± 0.5 10.5 ± 0.7 5.6 ± 0.5 7.5 ± 0.6
Phosphatidylcholine 68.8 ± 1.3 46.2 ± 1.4 71.5 ± 3.0 50.6 ± 1.7
Sphingomyelin 5.0 ± 0.2 12.5 ± 0.5 6.6 ± 0.5 19.9 ± 1.7
Others 3.6 ± 0.2 4.3 ± 0.5 3.7 ± 0.4 7.6 ± 0.7
a Mean ± SEM; n = 30.
b Mean ± SEM; n = 44.
(66), and isolated Type II cells (27,66). The lamellar
body ofthe Type II cell is the major site of surfactant-
associated esterase activity within the lung (66). In the
Type II cells of the organotypic cultures, the lamellar
body is also the major site ofesterase activity (30). The
nonspecific esterases of the cultured Type II cells
resemble those of whole rat and mouse lung homoge-
nates and pulmonary lavage fluid in biochemical,
cytochemical, and electrophoretic characteristics (30).
This finding yields additional evidence that organotypic
cultures of Type II cells retain surfactant-associated
functions of Type II cells in vivo.
The organotypic model has already been utilized to
study the effects of certain hormones upon production
of surfactant. In vivo, glucorticoids are known to
accelerate fetal lung maturation and surfactant produc-
tion although the mechanism of action for this effect is
not known (5). In the organotypic model, dexametha-
sone treatment produces a dose-dependent increase in
the synthesis and cellular content ofsurfactant PC and
surfactant PG but has no effect on the content of
synthesis ofresidual PC and residual PG (67). Thyroid
hormones have also been suggested to accelerate the
development of the fetal lung (68,69). Triiodothyronine
(T3) has been found to increase the PC content ofboth
surfactantandresidualfractions oforganotypiccultures;
residualPC increasesimmediately afterexposure toT3,
while surfactant PC is maximal after 24 hr ofexposure
to the hormone (70). Other hormones which have been
implicated as accelerators of fetal lung maturation in
vivo include estrogens (71) and prolactin (72).
Application to Pulmonary Toxicology
There are several areas of pulmonary toxicology
which might be explored more thoroughly with the
utilization ofthe organotypic model. One ofthe advan-
tages ofthis system is that it will allow a more accurate
knowledge ofthe dose ofan agent delivered to the Type
II cell than can be ascertained in vivo. In the animal,
factors such as temperature changes, hypoxia, pH
changes, damage to the vasculature, and clearance by
blood, alveolar fluid, and lymph will all have a potential
effect on the dose received by the Type II cells (73). In
addition, certain agents, such as SO2 and water-soluble
aerosols which are difficult to deliver to the alveolar
region in the whole animal because they impact in the
upper airways, could be employed relatively easily with
this model.
From studies utilizing lung homogenates, it is known
that changes in pulmonary enzymes occur after injury
(74). However, the mechanisms responsible for these
changes are not known. A frequently studied example
of this is the phenomenon of tolerance to oxygen or
ozone (74,75) which is thought to involve changes in the
enzyme activity of TMype II cells (39). A fetal organ
culture system similar to the organotypic model has
beenused tostudyoxygentoxicity(76). Theorganotypic
model might be applied to elucidate the mechanism of
this phenomenon more fully.
In vivo studies indicate that many pulmonary toxi-
cants decrease the synthesis of surfactant. This de-
crease in surfactant has been proposed as a sensitive
screen for pulmonary irritants because the decrease
often occurs before morphological changes are observed
(77). Gasoline vapors decrease surfactant in rat lungs
(77-79), as do trichloroethylene, carbon tetrachloride
and cigarette smoke (77). These changes can be de-
tected as early as 5 days after exposure (77). Fluorocar-
bonssuchasanesthetic agents(80), increasedconcentra-
tions of oxygen (81), and the ingestion ofparaquat (82)
also decrease surfactant production. The effect of irri-
tants on surfactant production could be studied further
with the use of the organotypic model system.
Viral respiratory infections may act additively with
chemical compounds in causing lung damage or carcino-
genesis (83,84). There is also evidence that pulmonary
infections decrease the number of lung tumors experi-
mentally induced (85,86). The organotypic system has
been used to study the response of Type II cells to
infection with certain respiratory viruses (87). It might
also be utilized to study the effect of interactions of
viruses with chemicals on the Type II cell.
Finally, it should be noted that lung tumors do arise
from Type II cells in humans (88-90), forming alveolar
cell cancers, bronchiolar-alveolar cancers, and pulmo-
nary adenomatosis. In humans, 1.5 to 5.0% of pulmo-
nary neoplasms are derived from Type II cells (38).
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Tpype II cells are also the origin of lung cancers in
animals such as sheep (91,92) and mice (93,94). The
mouse adenoma model has been proposed as another
screening method for lung carcinogens (94). The
organotypic model should be considered as anadditional
means for assessing the process of malignant transfor-
mation of the alveolar TIype II cell. This model might
prove especially helpful in estimating doses of carcino-
gens necessary for various preneoplastic and neoplastic
changes in the cells.
Summary and Conclusions
The Trype II cell plays a part in the response of the
lung to many toxic and carcinogenic agents as well as
being involved in such diseases as the respiratory
distress syndrom ofthe newborn. In addition, the Type
II cell is the stem cell of the alveolar epithelium and
serves as a reservoir for any damaged Type I cells.
Thus, any new model for the study of the Type II cell
and its functions can be very useful in understanding
mechanisms of injury to the peripheral lung. The fetal
lung organotypic culture system is such a model for it
possesses many advantages inherent in a tissue culture
system, andtheType IIcells alsoretainmanycharacter-
istics ofType II cells in vivo. The method for establish-
ing a fetal organotypic Type II culture depends upon
the histotypic reaggregation of fetal alveolar pneumo-
nocytes after the fetal lung has been enzymatically
digested. Thepneumonocytesgrowinalveolarlike struc-
tures upon a layer of fibroblasts. After a few days in
culture, the organotypic Type II cells are similar in
morphology to Type II cells in vivo. Surfactant pro-
duced by the organotypic cells has been characterized
biochemically and reflects the composition ofsurfactant
produced by the whole rat lung.
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